Population Benefits: the NHS’s new approach to assessing mergers

Last month NHS England and NHS Improvement (NHS E/I) published plans for a new approach to assessing NHS transactions that put more emphasis on ensuring local populations benefit from NHS mergers. Until recently, NHS transactions were overseen by NHS Improvement for organisational impacts (e.g. finance, organisational risk), and the Competition & Markets Authority (CMA) for competition….

Collaboration between pharma competitors: combination treatments for patients

Combination therapies use two or more drugs as part of a single treatment regime for an increasing number of diseases, such as cancer. Combination treatments can deliver better outcomes for patients by targeting a disease via multiple pathways or at multiple levels. Unfortunately, there are a number of barriers to making combination therapies more widely…

Andrew Taylor writes on increased NHS labour costs for HSJ

Andrew Taylor, a partner at Aldwych Partners, has written for the Health Service Journal (HSJ) this week on how efforts to clear the elective care backlog are likely to feed into higher clinician labour costs, even without a national pay rise. Clinicians willing to work extra time are likely to gravitate to those opportunities where…

CMA intervenes as CVS acquires The Vet

The CMA intervened for the first time in the vet sector last Friday, calling in CVS’s acquisition of The Vet for review. The vet sector has consolidated rapidly in recent years with large corporate chains acquiring many practices formerly owned by vets. New corporate owners have been willing to invest significant sums in premises and…

Increased NHS staff costs to bite into Health & Social Care Levy

While the NHS will get much of the money from the new Health & Social Care Levy in the next three years, yesterday’s Health Service Journal (HSJ) reported that senior NHS management expect it to be unable to deliver many of the goals in 2019’s Long Term Plan. A fundamental problem for the NHS is…